An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics - PubMed
6 days ago
- #Epigenetic Aging
- #Gerotherapeutics
- #Retrotransposons